Abbott Enters US PFA Market With Volt, Gets Clearance For Heart Delivery Device In Premature Babies
Abbott’s Dual FDA Clearances Highlights Its Expanding Cardiovascular Footprint, Spanning Both High-Growth AFib Ablation And Life-Saving Pediatric Heart Interventions.
The company is hopeful that Abbott’s device, which uses a balloon-in-basket design and can integrate with a 3D mapping system, will bring an edge over competitors.
